Analysts think TEM stock price could increase by 25%
Mar 28, 2025, 11:25 AM
-0.69%
What does TEM do
Tempus AI, based in Chicago, Illinois, went public on June 14, 2024, providing next-generation diagnostics through genomics and AI applications aimed at personalizing medicine. Its primary product, Next, uses machine learning to enhance oncology and cardiology care.
10 analysts think TEM stock price will increase by 24.51%. The current median analyst target is $66.30 compared to a current stock price of $53.25. The lowest analysts target is $55.55 and the highest analyst target is $77.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!